These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism. Lewis NJ, Feller DR, Poochikian GK, Witiak DT. J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468 [No Abstract] [Full Text] [Related]
4. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models. Cavestri RC, Minatelli JA, Baldwin JR, Loh W, Feller DR, Newman HA, Sober CL, Witiak DT. Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078 [Abstract] [Full Text] [Related]
5. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals. O'Brien M, Patel ST, Mukhopadhyay A, Newman HA, Feller DR, Kokrady SS, Witiak DT, Lanese RR, Rice JC. Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211 [Abstract] [Full Text] [Related]
6. Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium. Jahromi MA, Ray AB. J Nat Prod; 1993 Jul; 56(7):989-94. PubMed ID: 8377021 [Abstract] [Full Text] [Related]
7. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model. Witiak DT, Newman HA, Poochikian GK, Loh W, Sankarappa SK. Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976 [Abstract] [Full Text] [Related]
8. Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model. Witiak DT, Heilman WP, Sankarappa SK, Cavestri RC, Newman HA. J Med Chem; 1975 Sep; 18(9):935-42. PubMed ID: 1159716 [Abstract] [Full Text] [Related]
11. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate. Witiak DT, Newman HA, Poochikian GK, Fogt SW, Baldwin JR, Sober CL, Feller DR. J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517 [Abstract] [Full Text] [Related]
16. Pharmacological studies on experimental nephritic rats. (4) Improvement of hyperlipemic models in rats utilizing anti-rat kidney rabbit serum and effects of anti-hyperlipemic agents on serum lipid levels. Suzuki Y, Honda Y, Ito M. Jpn J Pharmacol; 1978 Oct; 28(5):729-38. PubMed ID: 723001 [Abstract] [Full Text] [Related]
18. Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice. da Rocha JT, Sperança A, Nogueira CW, Zeni G. J Pharm Pharmacol; 2009 Dec; 61(12):1673-9. PubMed ID: 19958591 [Abstract] [Full Text] [Related]
19. The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins. Gustafsson K, Kiessling H. Z Versuchstierkd; 1982 Dec; 24(5-6):262-70. PubMed ID: 7170838 [No Abstract] [Full Text] [Related]